NewsBite analysis · HealthTech, ScienceTech
euronews
Congo's Ebola outbreak is far smaller than initially feared, WHO says
The latest update from the World Health Organization indicates that Congo's current Ebola outbreak is substantially smaller than early projections suggested. As of May 31, there are 116 suspected and 321 confirmed cases, with 48 deaths reported and several recoveries. The reduction in suspected cases is attributed to testing that ruled out other illnesses, underscoring the importance of rapid diagnosis and isolation. While the Bundibugyo strain remains relatively uncommon and lacks targeted treatments or vaccines, global health actors are prioritizing vaccine development. The Coalition for Epidemic Preparedness Innovations (CEPI) announced plans to accelerate vaccine candidates and invest up to €53 million in a portfolio involving IAVI, Moderna, and the University of Oxford, with Serum Institute of India slated for manufacturing. The news highlights continued containment challenges and the ongoing search for preventive measures, even as the immediate outbreak appears less severe than initially feared.
MonitorConfidence: HighShort term horizon
Published 3 Jun 2026, 11:10 UTC2 min read
Visit original article ↗Lead image — euronews
Summary
TL;DR
- WHO revises down Ebola case counts in Congo
- 116 suspected, 321 confirmed cases as of May 31
- 48 deaths reported; some recoveries confirmed
- Testing cleared many patients of Ebola-like symptoms
- CEPI to fund up to €53 million for Bundibugyo vaccines
- IAVI, Moderna, Oxford collaborating; SII to manufacture vaccines
Interesting facts
- Bundibugyo Ebola virus is less common and complicates treatment development
- No targeted vaccines or treatments exist yet for this strain
- Uganda reported additional cases and a death related to the broader regional activity